<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03895723</url>
  </required_header>
  <id_info>
    <org_study_id>RSRCLM-02</org_study_id>
    <nct_id>NCT03895723</nct_id>
  </id_info>
  <brief_title>Minimally Invasive Versus Open Liver Resection for Patients With Colorectal Cancer Liver Metastases</brief_title>
  <official_title>Minimally Invasive(Laparoscopic and Robotic) Versus Open Liver Resection for Patients With Colorectal Cancer Liver Metastases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xu jianmin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fudan University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To examine survival of patients who underwent minimally invasive versus open liver resection
      for colorectal cancer with liver metastases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      the minimally invasive procedure contain laparoscopic or robotic surgery
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">April 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Arm A: minimally invasive surgery Arm B: open</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The assessor was masking for patients treatment arms</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>disease-free survival (DFS)</measure>
    <time_frame>3 years disease-free survival</time_frame>
    <description>DFS was calculated from the date of liver resection to the date of death or recurrence or new tumors developing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall survival (OS)</measure>
    <time_frame>5 years overall survival</time_frame>
    <description>OS was calculated from the date of liver resection to the date of death with any reason</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sugical complications</measure>
    <time_frame>1 months after sugery</time_frame>
    <description>According to Claivein-Dindo surgical complication system to calculate the perioperative complications related to surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Colorectal Liver Metastasis</condition>
  <arm_group>
    <arm_group_label>Minimally Invasive surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the intevention of Minimally Invasive procedure contains laparoscopic and robotic liver resection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Open surgery</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>the open surgery means traditional open surgery for liver resection</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic and robotic liver resection</intervention_name>
    <description>laparoscopic and robotic procedure for liver resection</description>
    <arm_group_label>Minimally Invasive surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>open surgery</intervention_name>
    <description>using open surgery procedure for liver resection</description>
    <arm_group_label>Open surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients were diagnosed with colorectal cancer liver metastases

          -  without extra-hepatic liver metastases

          -  age were within 18-75 yeas

          -  the numbers of metastases more than 3

          -  the maximal tumor size of liver metastases more than 10 cm

        Exclusion Criteria:

          -  liver metastases were unresectable.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Wenju Chang</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenju Chang, MD</last_name>
      <phone>+8613764476150</phone>
      <email>chang_erich@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>June 28, 2017</study_first_submitted>
  <study_first_submitted_qc>March 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2019</study_first_posted>
  <last_update_submitted>March 27, 2019</last_update_submitted>
  <last_update_submitted_qc>March 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Fudan University</investigator_affiliation>
    <investigator_full_name>Xu jianmin</investigator_full_name>
    <investigator_title>Director of colorectal cancer center</investigator_title>
  </responsible_party>
  <keyword>Colorectal liver metastasis</keyword>
  <keyword>Minimally invasive surgery</keyword>
  <keyword>Robotic surgery</keyword>
  <keyword>Laparoscopic surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Neoplasms, Second Primary</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

